In the latest trading session,, 16.02 million Helius Medical Technologies Inc (NASDAQ:HSDT) shares changed hands as the company’s beta touched 0.75. With the company’s most recent per share price at $11.62 changing hands around $2.72 or 30.56% at last look, the market valuation stands at $7.86M. HSDT’s current price is a discount, trading about -10227.02% off its 52-week high of $1200.00. The share price had its 52-week low at $7.15, which suggests the last value was 38.47% up since then. When we look at Helius Medical Technologies Inc’s average trading volume, we note the 10-day average is 85340.0 shares, with the 3-month average coming to 150.35K.
Analysts gave the Helius Medical Technologies Inc (HSDT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended HSDT as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Helius Medical Technologies Inc’s EPS for the current quarter is expected to be 0.
Helius Medical Technologies Inc (NASDAQ:HSDT) trade information
Instantly HSDT is in green as seen in intraday trades today. With action 58.10%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -98.24%, with the 5-day performance at 58.10% in the green. However, in the 30-day time frame, Helius Medical Technologies Inc (NASDAQ:HSDT) is -35.50% down. Looking at the short shares, we see there were 46708.0 shares sold at short interest cover period of 0.21 days.
Helius Medical Technologies Inc (HSDT) estimates and forecasts
Year-over-year growth is forecast to reach -28.08% down from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 75k. 1 analysts are of the opinion that Helius Medical Technologies Inc’s revenue for the current quarter will be 110k. The company’s revenue for the corresponding quarters a year ago was 182k and 51k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -58.79%. The estimates for the next quarter sales put growth at 115.69%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 63.29%. The 2025 estimates are for Helius Medical Technologies Inc earnings to increase by 92.20%.
HSDT Dividends
Helius Medical Technologies Inc is expected to release its next quarterly earnings report on 2025-May-01.
Helius Medical Technologies Inc (NASDAQ:HSDT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 17.70% of Helius Medical Technologies Inc shares while 6.31% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.67%.
Among Mutual Funds, the top two as of May 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 38.0 shares estimated at $411.0 under it, the former controlled 0.01% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.00% of the shares, roughly 8.0 shares worth around $86.0.
